KENTA YAMAMOTO

Dr. KENTA YAMAMOTO

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2023 in Alimentary Pharmacology & Therapeutics
Verified
Journal Article
Closed access
SIShuji Ikegami
Shuji Ikegami
MNMasanao Nakamura
Masanao Nakamura
THTakashi Honda
Takashi Honda
TYTakeshi Yamamura
Takeshi Yamamura
KMKeiko Maeda
Keiko Maeda
HKHiroki Kawashima
Hiroki Kawashima

22 August 2019 in eLife
Verified
Journal Article
Open access
KYKENTA YAMAMOTO
KENTA YAMAMOTO
VDVikas Dubey
Vikas Dubey
KIKatsumasa Irie
Katsumasa Irie
HNHanayo Nakanishi
Hanayo Nakanishi
HKHimanshu Khandelia
Himanshu Khandelia
KAKazuhiro Abe
Kazuhiro Abe
The gastric proton pump (H+,K+-ATPase), a P-type ATPase responsible for gastric acidification, mediates electro-neutral exchange of H+ and K+ coupled with ATP hydrolysis, but with an as yet undetermined transport stoichiometry. Here we show crystal structures at a resolution of 2.5 Å of the pump in the E2-P transition state, in which the counter-transporting cation is occluded. We found a single K+ bound to the cation-binding site of the H+,K+-ATPase, indicating an exchange of 1H+/1K+ per hydrolysis of one ATP molecule. This fulfills the energy requirement for the generation of a six pH unit gradient across the membrane. The structural basis of K+ recognition is resolved and supported by molecular dynamics simulations, establishing how the H+,K+-ATPase overcomes the energetic challenge to generate an H+ gradient of more than a million-fold—one of the highest cation gradients known in mammalian tissue—across the membrane.

29 April 2024 in Clinical Nutrition
Verified
Journal Article
Open access
SYShinya Yokoyama
Shinya Yokoyama
THTakashi Honda
Takashi Honda
YIYoji Ishizu
Yoji Ishizu
Norihiro ImaiNorihiro Imai
Norihiro Imai
TITakanori Ito
Takanori Ito
HKHiroki Kawashima
Hiroki Kawashima
Steatotic liver disease (SLD) is often detected in health examinations. However, although individuals with metabolic dysfunction-associated SLD (MASLD) may have decreased bone mineral density (BMD), the specific risk factors remain unclarified. The objective of this study was to identify the factors associated with decreased BMD in patients with MASLD. Individuals who underwent abdominal ultrasonography and BMD measurements at our healthcare center were included. The BMD of the calcaneus was assessed using an AOS-10SA bone densitometer. Decreased BMD was defined as a T-score below -1.0 SD or the administration of osteoporosis treatment. SLD was diagnosed based on specific ultrasonographic criteria. A total of 1410 patients were diagnosed with MASLD. The median age was 52 years. Multivariate analysis using a logistic regression model revealed that the independent predictors of decreased BMD were a low body mass index (BMI) or a small waist circumference (odds ratio (OR): 0.48, 95% confidence interval (CI): 0.34-0.67), hypertriglyceridemia (OR: 1.29, 95% CI: 1.00-1.65), and a weak grip strength (OR: 0.98, 95% CI: 0.97-1.00). Subgroup analyses of individuals aged 50 years or older, men, and individuals with a FIB-4 index of 1.3 or greater revealed that the absence of a high BMI or a large waist circumference was associated with decreased BMD. The subgroup analysis of men revealed that a weaker grip strength was associated with decreased BMD. The present study suggested several potential risk factors for decreased BMD in patients with MASLD. Individuals with the abovementioned risk factors should be encouraged to undergo BMD measurement from the perspective of preventive medicine.

19 March 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
KYKENTA YAMAMOTO
KENTA YAMAMOTO
THTakashi Honda
Takashi Honda
YIYosuke Inukai
Yosuke Inukai
SYShinya Yokoyama
Shinya Yokoyama
TITakanori Ito
Takanori Ito
HKHiroki Kawashima
Hiroki Kawashima
We investigated the prognostic role of the gut microbiome and clinical factors in chronic liver disease (hepatitis, cirrhosis, and hepatocellular carcinoma [HCC]). Utilizing data from 227 patients whose stool samples were collected over the prior 3 years and a Cox proportional hazards model, we integrated clinical attributes and microbiome composition based on 16S ribosomal RNA sequencing. HCC was the primary cause of mortality, with the Barcelona Clinic Liver Cancer staging system-derived B/C significantly increasing the mortality risk (hazard ratio [HR] = 8.060; 95% confidence interval [CI]: 3.6509–17.793; p < 0.001). Cholesterol levels < 140 mg/dL were associated with higher mortality rates (HR = 4.411; 95% CI: 2.0151–9.6555; p < 0.001). Incertae sedis from Ruminococcaceae showed a protective effect, reducing mortality risk (HR = 0.289; 95% CI: 0.1282 to 0.6538; p = 0.002), whereas increased Veillonella presence was associated with a higher risk (HR = 2.733; 95% CI: 1.1922–6.2664; p = 0.017). The potential of specific bacterial taxa as independent prognostic factors suggests that integrating microbiome data could improve the prognosis and treatment of chronic liver disease. These microbiome-derived markers have prognostic significance independently and in conjunction with clinical factors, suggesting their utility in improving a patient’s prognosis.


18 August 2008 in BMC Public Health
Verified
Journal Article
Open access
PDF file
MMMasae Miyatani
Masae Miyatani
HKHiroshi Kawano
Hiroshi Kawano
KMKei Masani
Kei Masani
YGYuko Gando
Yuko Gando
KYKENTA YAMAMOTO
KENTA YAMAMOTO
MMMotohiko Miyachi
Motohiko Miyachi
Since it is essential to maintain a high level of cardiorespiratory fitness to prevent life-style related disease, the Ministry of Health, Labour and Welfare of Japan in 2006 proposed to determine the maximal oxygen uptake (Vo2max: mL·kg-1·min-1) reference values to prevent life-style related diseases (LSRD). Since muscle mass is one of the determinant factors of Vo2max, it could be used as the reference parameter for preventing LSRD. The aim of this study was to determine and quantify the muscle mass required to maintain the Vo2max reference values in Japanese women.